Multiplexed bioluminescence-mediated tracking of DNA double-strand break repairs in vitro and in vivo
The dynamics of DNA double-strand break (DSB) repairs including homology-directed repair and nonhomologous end joining play an important role in diseases and therapies. However, investigating DSB repair is typically a low-throughput and cross-sectional process, requiring disruption of cells and orga...
Saved in:
Published in | Nature protocols Vol. 16; no. 8; pp. 3933 - 3953 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.08.2021
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The dynamics of DNA double-strand break (DSB) repairs including homology-directed repair and nonhomologous end joining play an important role in diseases and therapies. However, investigating DSB repair is typically a low-throughput and cross-sectional process, requiring disruption of cells and organisms for subsequent nuclease-, sequencing- or reporter-based assays. In this protocol, we provide instructions for establishing a bioluminescent repair reporter system using engineered
Gaussia
and
Vargula
luciferases for noninvasive tracking of homology-directed repair and nonhomologous end joining, respectively, induced by SceI meganuclease, SpCas9 or SpCas9 D10A nickase-mediated editing. We also describe complementation with orthogonal DSB repair assays and omics analyses to validate the reporter readouts. The bioluminescent repair reporter system provides longitudinal and rapid readout (~seconds per sample) to accurately and efficiently measure the efficacy of genome-editing tools and small-molecule modulators on DSB repair. This protocol takes ~2–4 weeks to establish, and as little as 2 h to complete the assay. The entire bioluminescent repair reporter procedure can be performed by one person with standard molecular biology expertise and equipment. However, orthogonal DNA repair assays would require a specialized facility that performs Sanger sequencing or next-generation sequencing.
This protocol sets up a bioluminescent repair reporter system using engineered
Gaussia
and
Vargula
luciferases for noninvasive tracking of homology-directed repair and nonhomologous end joining, respectively, induced by SceI meganuclease, SpCas9 or SpCas9 D10A nickase-mediated editing. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 Christian E. Badr, Department of Neurology, Massachusetts General Hospital, 149 13th Street, Charlestown, MA, 02129, USA. Present Address Charles P. Lai, Institute of Atomic and Molecular Sciences, Academia Sinica, No. 1, Roosevelt Rd., Sec. 4, Taipei 10617, Taiwan. C.P.L and C.E.B. conceived and designed the study. J.C.C. conducted the in vitro experiments and developed the procedures. C.E.B developed the in vivo procedures. The manuscript was written by J.C.C. and C.E.B. and C.P.L with input from all authors. Author contributions statement |
ISSN: | 1754-2189 1750-2799 1750-2799 |
DOI: | 10.1038/s41596-021-00564-8 |